UK markets closed

Axsome Therapeutics, Inc. (AXSM)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
71.24-0.28 (-0.39%)
As of 12:29PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts14131512
Avg. Estimate-1.21-1.03-3.861.03
Low estimate-1.45-1.26-5.02-2.51
High estimate-0.98-0.75-24.9
Year ago EPS-0.26-1.54-5.27-3.86
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts14141615
Avg. Estimate73.47M87.39M373.84M693.51M
Low estimate65.7M80.5M339.58M538.95M
High estimate84.76M95M442.8M942.55M
Year ago sales26.07M40.93M270.6M373.84M
Sales growth (year/est)181.80%113.50%38.20%85.50%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-1.04-1.22-1.2-1.17
Actual EPS-0.26-1.54-1.32-2.08
Difference0.78-0.32-0.12-0.91
Surprise %75.00%-26.20%-10.00%-77.80%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-1.21-1.03-3.861.03
7 days ago-1.18-1-3.771.13
30 days ago-1.2-1.03-3.790.99
60 days ago-1.19-1.03-3.710.68
90 days ago-1.08-0.9-3.091.6
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/A1
Up last 30 days2122
Down last 7 daysN/AN/AN/AN/A
Down last 30 days2221
Growth estimatesAXSMIndustrySector(s)S&P 500
Current qtr.-365.40%N/AN/AN/A
Next qtr.33.10%N/AN/AN/A
Current year26.80%N/AN/AN/A
Next year126.70%N/AN/AN/A
Next 5 years (per annum)187.90%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A